MCL coexpression mm9:641
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr10:79132158..79132204,+ | p@chr10:79132158..79132204 + |
Mm9::chr11:78141927..78141974,+ | p1@Pigs |
Mm9::chr2:131005721..131005828,- | p1@Cenpb |
Mm9::chr2:32837527..32837606,- | p1@Slc2a8 |
Mm9::chr5:120953602..120953636,- | p1@Plbd2 |
Mm9::chr5:24092539..24092612,+ | p1@Chpf2 |
Mm9::chr7:149573800..149573811,- | p3@Ctsd |
Mm9::chr7:52765770..52765783,- | p2@Nucb1 |
Mm9::chr8:26127724..26127777,+ | p1@Tm2d2 |
Mm9::chr8:26127778..26127792,+ | p2@Tm2d2 |
Mm9::chrX:71638550..71638606,- | p2@Fam3a |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0005536 | glucose binding | 0.00542376595628116 |
GO:0015284 | fructose uniporter activity | 0.00542376595628116 |
GO:0015757 | galactose transport | 0.00542376595628116 |
GO:0004192 | cathepsin D activity | 0.00542376595628116 |
GO:0015755 | fructose transport | 0.00542376595628116 |
GO:0005354 | galactose transmembrane transporter activity | 0.00542376595628116 |
GO:0015292 | uniporter activity | 0.00542376595628116 |
GO:0008516 | hexose uniporter activity | 0.00542376595628116 |
GO:0005353 | fructose transmembrane transporter activity | 0.00964092987743474 |
GO:0003923 | GPI-anchor transamidase activity | 0.0130134726345087 |
GO:0004194 | pepsin A activity | 0.0315262134324555 |
GO:0005355 | glucose transmembrane transporter activity | 0.0340455772610801 |
GO:0015145 | monosaccharide transmembrane transporter activity | 0.0340455772610801 |
GO:0015149 | hexose transmembrane transporter activity | 0.0340455772610801 |
GO:0004190 | aspartic-type endopeptidase activity | 0.0475920528897136 |
GO:0006506 | GPI anchor biosynthetic process | 0.0475920528897136 |
GO:0048029 | monosaccharide binding | 0.0475920528897136 |
GO:0046489 | phosphoinositide biosynthetic process | 0.0475920528897136 |
GO:0001666 | response to hypoxia | 0.0475920528897136 |
GO:0006505 | GPI anchor metabolic process | 0.0475920528897136 |
GO:0008286 | insulin receptor signaling pathway | 0.0484175615673511 |
GO:0015758 | glucose transport | 0.0484175615673511 |
GO:0044444 | cytoplasmic part | 0.0484175615673511 |
GO:0008645 | hexose transport | 0.0484175615673511 |
GO:0015749 | monosaccharide transport | 0.0484175615673511 |
GO:0046474 | glycerophospholipid biosynthetic process | 0.049867069573456 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
non-terminally differentiated cell | 1.05e-14 | 49 |
ectodermal cell | 9.36e-12 | 44 |
neurectodermal cell | 9.36e-12 | 44 |
neural cell | 2.15e-11 | 43 |
electrically responsive cell | 8.22e-10 | 39 |
electrically active cell | 8.22e-10 | 39 |
embryonic cell | 1.75e-09 | 70 |
neuron | 7.31e-07 | 33 |
neuronal stem cell | 7.31e-07 | 33 |
neuroblast | 7.31e-07 | 33 |
electrically signaling cell | 7.31e-07 | 33 |
oligodendrocyte precursor cell | 9.93e-07 | 8 |
Ontology term | p-value | n |
---|---|---|
nervous system | 6.89e-21 | 75 |
central nervous system | 9.36e-21 | 73 |
ectoderm-derived structure | 1.14e-17 | 95 |
ectoderm | 1.14e-17 | 95 |
presumptive ectoderm | 1.14e-17 | 95 |
anatomical conduit | 1.84e-16 | 122 |
regional part of nervous system | 3.80e-16 | 54 |
neural tube | 6.56e-15 | 52 |
neural rod | 6.56e-15 | 52 |
future spinal cord | 6.56e-15 | 52 |
neural keel | 6.56e-15 | 52 |
tube | 7.15e-15 | 114 |
structure with developmental contribution from neural crest | 1.06e-13 | 92 |
neurectoderm | 1.12e-12 | 64 |
neural plate | 1.12e-12 | 64 |
presumptive neural plate | 1.12e-12 | 64 |
brain | 3.30e-12 | 47 |
future brain | 3.30e-12 | 47 |
regional part of brain | 3.68e-12 | 46 |
ecto-epithelium | 1.07e-11 | 73 |
anterior neural tube | 4.21e-10 | 40 |
regional part of forebrain | 8.26e-10 | 39 |
forebrain | 8.26e-10 | 39 |
future forebrain | 8.26e-10 | 39 |
gray matter | 1.11e-09 | 34 |
anatomical system | 2.49e-08 | 308 |
anatomical group | 2.49e-08 | 308 |
pre-chordal neural plate | 2.97e-08 | 49 |
brain grey matter | 1.95e-07 | 29 |
regional part of telencephalon | 1.95e-07 | 29 |
telencephalon | 1.95e-07 | 29 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |